Skip to content

Health

Rising applied sciences in healthcare, half 5: Augmedics

Rising applied sciences in healthcare, half 5: Augmedics

Health|June 17, 2025by t49nq

Editor’s observe: Whereas Nissan Elimelech based Augmedics and invented its foundational know-how,

Metropolis of Hope examine targets custom-built most cancers therapies

Health|June 17, 2025by t49nq

Most cancers analysis group Metropolis of Hope has co-led a examine to

Volcano Rooster Recipe in Below 30 Minutes

Health|June 17, 2025by t49nq

As soon as I began my pure well being journey, I spotted

Singaporean medical doctors develop agentic AI-powered scribe

Health|June 17, 2025by t49nq

In recent times, scientific documentation enchancment instruments have more and more change

InSilicoTrials turns into a part of Microsoft for Startups Pegasus Program

Health|June 16, 2025by t49nq

InSilicoTrials, a well being tech firm that develops AI-based simulation to foretell

Anne Wojcicki will purchase 23andMe for $305M following chapter

Health|June 16, 2025June 16, 2025by t49nq

Anne Wojcicki, cofounder and former CEO of 23andMe, will regain management of

Methods to Know When Your Meat is Truly Cooked With out Overcooking It

Health|June 16, 2025by t49nq

If you happen to purchase expensive steaks, it’s essential to know inform

Tombot secures $6.1M for robotic pet

Health|June 13, 2025by t49nq

Tombot, a California-based robotics firm that makes a robotic pet that serves

Ellipsis Well being secures $45M, launches AI care supervisor

Health|June 13, 2025by t49nq

Ellipsis Well being, an organization utilizing AI voice agent know-how, introduced it

Q&A: The affect of tariffs on the healthcare provide chain

Health|June 13, 2025June 13, 2025by t49nq

Michael Needham, principal at Efficio, a worldwide provide chain procurement consultancy, sat

  • Prev
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 54
  • Next
Copyright © 2024 cekktp.com - All right reserved
  • Index
  • About
  • Terms and Conditions
  • Contact
Non AMP Version
  • Health
  • About
  • Contact
  • Indeks Berita
  • Terms and Conditions
Exit mobile version